Page last updated: 2024-09-05

erlotinib hydrochloride and theobromine

erlotinib hydrochloride has been researched along with theobromine in 1 studies

Compound Research Comparison

Studies (erlotinib hydrochloride)	Trials (erlotinib hydrochloride)	Recent Studies (post-2010) (erlotinib hydrochloride)	Studies (theobromine)	Trials (theobromine)	Recent Studies (post-2010) (theobromine)
4,353	786	3,033	1,864	174	274

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Alsfouk, AA; Eissa, IH; Elkady, H; Elkaeed, EB; Husein, DZ; Ibrahim, IM; Metwaly, AM; Yousef, RG	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and theobromine

Article	Year
New Anticancer Theobromine Derivative Targeting EGFR Molecules (Basel, Switzerland), 2022, Sep-09, Volume: 27, Issue:18 Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Structure-Activity Relationship; Theobromine	2022

Article

Year

New Anticancer Theobromine Derivative Targeting EGFR

Molecules (Basel, Switzerland), 2022, Sep-09, Volume: 27, Issue:18

Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Molecular Docking Simulation; Molecular Structure; Mutation; Protein Kinase Inhibitors; Structure-Activity Relationship; Theobromine

2022